These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8658566

  • 1. [The use of immunological indices for assessing the severity of the course of periodontitis and treatment efficacy].
    Bazhanov NN, Ter-Asaturov GP, Kassin VIu, Ivaniushko TP, Arion VIa, Simonova AV.
    Stomatologiia (Mosk); 1996; 75(1):15-8. PubMed ID: 8658566
    [Abstract] [Full Text] [Related]

  • 2. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE, Vasil'ev AV, Sakharova IIa, Machkova NA, Ivanova LA.
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract] [Full Text] [Related]

  • 3. [The clinico-immunological effects of T-activin in the combined treatment of patients with acute suppurative pyelonephritis].
    Vozianov AF, Drannik GN, Pasechnikov SP, Driianskaia VE, Petrovskaia IA, Kushko LIa, Ozvinchuk II, Potrebinskiĭ VM, Milinevskiĭ VA.
    Lik Sprava; 1995; (9-12):81-3. PubMed ID: 8983802
    [Abstract] [Full Text] [Related]

  • 4. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
    Ianiushina VV.
    Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
    Drobyshev VIu, Volozhin AI, Agapov VS, Sashkina TI.
    Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
    Sakhelashvili-Haladzhun MI.
    Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
    [Abstract] [Full Text] [Related]

  • 11. [Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin].
    Chuvirov GN, Markova TP.
    Ter Arkh; 1986; 58(9):67-70. PubMed ID: 3787495
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of using T-activin in the therapy of the newborn with suppurative surgical infection.
    Samsygin SA, Dolgina EN, Arion VYa, Romanova LA, Shchevochkina GI, Ovchinnikova EA.
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(3):269-76. PubMed ID: 2809182
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.